Quantbot Technologies LP Annexon, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.74 - $7.46 $748 - $1,492	-200 Reduced 20.0%	800 $3,000
Q4 2022 Feb 13, 2023	SELL	$4.56 - $6.61 $6,383 - $9,254	-1,400 Reduced 58.33%	1,000 $5,000
Q3 2022 Nov 07, 2022	SELL	$3.75 - $6.63 $19,875 - $35,139	-5,300 Reduced 68.83%	2,400 $14,000
Q2 2022 Aug 09, 2022	SELL	$2.11 - $4.06 $3,798 - $7,307	-1,800 Reduced 18.95%	7,700 $29,000
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $22,386 - $97,908	8,200 Added 630.77%	9,500 $25,000
Q4 2021 Feb 11, 2022	BUY	$11.49 - $22.0 $8,043 - $15,400	700 Added 116.67%	1,300 $14,000
Q3 2021 Nov 09, 2021	BUY	$16.35 - $23.4 $9,810 - $14,040	600 New	600 $11,000

157

101M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $344M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.